A randomised controlled trial to compare the efficacy, safety, and tolerability of low dose, short course primaquine in adults with uncomplicated P. vivax malaria in two hospitals in India
This study will evaluate the efficacy and safety of a 7-day primaquine regimen compared to the standard 14-day regimen in India. Results from this trial are likely to directly inform national treatment guidelines.Trial registrationTrial is registered on CTRI portal, Registration No: CTRI/2022/12/048283. (Source: Trials)
Source: Trials - February 29, 2024 Category: Research Source Type: clinical trials
Operational Feasibility of Appropriate Plasmodium Vivax Radical Cure After G6PD Testing in Thailand
Conditions: Malaria, Vivax; G6PD Deficiency Interventions: Drug: Tafenoquine; Drug: Primaquine Sponsors: Dr. Prayuth Sudathip; Medicines for Malaria Venture Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 3, 2023 Category: Research Source Type: clinical trials
Oxidative Stress, Carbohydrate Metabolism Disorders and G6PD Deficiency
Conditions: G6PD Deficiency; Carbohydrate Metabolism Disorder; Oxidative Stress Interventions: Dietary Supplement: Alpha-lipoic acid; Other: Placebo Sponsor: University of Thessaly Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 7, 2022 Category: Research Source Type: clinical trials
